Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

Journal: Nature Genetics

Published: 2020-04-27

DOI: 10.1038/s41588-020-0611-8

Affiliations: 132

Authors: 152

Go to article
Institutions Share
NIH NCI Division of Cancer Epidemiology and Genetics (DCEG), United States of America (USA) 0.09
QIMR Berghofer Cancer Division, Australia 0.03
Centre for Cancer Genetic Epidemiology (CCGE), University of Cambridge, United Kingdom (UK) 0.03
Instituto Valenciano de Oncologia (IVO), Spain 0.03
Faculty of Medicine, UOA, Greece 0.03
QIMR Berghofer Genetic Epidemiology Laboratory, Australia 0.03
Leeds Institute of Medical Research at St James's (LIMR), University of Leeds, United Kingdom (UK) 0.02
Leeds Institute for Data Analytics (LIDA), United Kingdom (UK) 0.02
Leidos Biomedical Research, Inc., United States of America (USA) 0.02
IRCCS Istituto Oncologico Veneto (IOV), Italy 0.02
Toxicology Pharmacology and Cellular Signaling, France 0.02
Institute for Molecular Bioscience (IMB), UQ, Australia 0.02
IRCCS Azienda Ospedaliera Universitaria San Martino, Italy 0.02
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain 0.02
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain 0.02
QIMR Berghofer Statistical Genetics Laboratory, Australia 0.01
Department of Dermatology, Leiden University, Netherlands 0.01
Translational Research Institute (TRI), Australia 0.01
West Hertfordshire Hospitals NHS Trust, United Kingdom (UK) 0.01
Dermatology Research Centre, Australia 0.01
UiO Rikshospitalet, Norway 0.01
Department of Epidemiology, IUPUI, United States of America (USA) 0.01
Department of Health Sciences (DSS), UNIFI, Italy 0.01
Department of Twin Research and Genetic Epidemiology, KCL, United Kingdom (UK) 0.01
Department of Surgical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.01
Department of Biostatistics, U-M, United States of America (USA) 0.01
Department of Biotechnological and Applied Clinical Sciences, UNIVAQ, Italy 0.01
Azienda Ospedaliera Papa Giovanni XXIII, Italy 0.01
IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy 0.01
Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università di Genova, Italy 0.01
The University of Queensland Diamantina Institute (UQDI), UQ, Australia 0.01
Duncan Guthrie Institute of Medical Genetics, University of Glasgow, United Kingdom (UK) 0.01
Princess Alexandra Hospital, Australia 0.01
QIMR Berghofer Laboratory of Inflammatory Bowel Diseases, Australia 0.01
The University of Sydney (USYD), Australia 0.01
Melanoma Institute Australia, Australia 0.01
Department of Pathology and Laboratory Medicine, Penn, United States of America (USA) 0.01
QIMR Berghofer Oncogenomics Laboratory, Australia 0.01
Hauttumorzentrum Hornheide-Münster, Fachklinik Hornheid, Germany 0.01
Karolinska University Hospital, Sweden 0.01
Department of Oncology-Pathology, KI, Sweden 0.01
Department of Anesthesiology, U-M, United States of America (USA) 0.01
Division of Surgery, LU, Sweden 0.01
Division of Surgery, Institute of Oncology Ljubljana, Slovenia 0.01
Department of Cancer Epidemiology, MOFFITT, United States of America (USA) 0.01
Department of Dermatology, Brown University, United States of America (USA) 0.01
Division of Molecular Genetic Epidemiology, DKFZ, Germany 0.01
McGill University and Génome Québec Innovation Centre, Canada 0.01
ICR Breast Cancer Now Toby Robins Research Centre, United Kingdom (UK) 0.01
International Hereditary Cancer Center (IHCC), PMU, Poland 0.01
Centre for Genetic Origins of Health and Disease (GOHaD), Australia 0.01
Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Slovenia 0.01
Department of Cardiovascular Sciences, University of Leicester, United Kingdom (UK) 0.01
NIH National Human Genome Research Institute (NHGRI), United States of America (USA) 0.01
Department of Community and Family Medicine, Dartmouth College, United States of America (USA) 0.01
Maurizio Bufalini Hospital, Italy 0.01
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Spain 0.01
Department of Electron Microscopy and Molecular Pathology, CING, Cyprus 0.01
Cyprus School of Molecular Medicine (CSMM), CING, Cyprus 0.01
Center for Statistical Genetics (CSG), U-M, United States of America (USA) 0.01
IRCCS Dipartimento Oncologia Medica, Italy 0.01
Ninewells Hospital and Medical School, United Kingdom (UK) 0.01
Centre of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), France 0.01
Fondazione Policlinico Universitario Agostino Gemelli, Italy 0.01
MRC Institute of Genetics and Molecular Medicine (IGMM), United Kingdom (UK) 0.01
School of Medicine, UCSC, Italy 0.01
Cochin Hospital, France 0.01
NIHR Leicester Respiratory Biomedical Research Unit (BRU), United Kingdom (UK) 0.01
Chaim Sheba Medical Center at Tel HaShomer, Israel 0.01
Sackler Faculty of Medicine, TAU, Israel 0.01
QIMR Berghofer Medical Research Institute, Australia 0.01
Menzies Institute for Medical Research, UTAS, Australia 0.01
Department of Genetics, MD Anderson Cancer Center, United States of America (USA) 0.01
Department of Genetics and Pathology, PMU, Poland 0.01
Flinders Centre for Ophthalmology, Eye and Vision Research (FCOEVR), Flinders University, Australia 0.01
Department of Pathology, Haukeland University Hospital, Norway 0.01
Department of Clinical Medicine (K1), UiB, Norway 0.01
Department of Clinical Genetics, Leiden University, Netherlands 0
Center for Human and Clinical Genetics, Leiden University, Netherlands 0
Department of Epidemiology and Biostatistics, MSKCC, United States of America (USA) 0
German Consortium of Translational Cancer Research (DKTK), Germany 0
Clinic for Dermatology, UDE, Germany 0
Department of Cancer Epidemiology, LU, Sweden 0
ICR Division of Genetics and Epidemiology, United Kingdom (UK) 0
Department of Epidemiology and Biostatistics (EBS), ICL, United Kingdom (UK) 0
Department of Hygiene and Epidemiology, UOI, Greece 0
Harvard T.H. Chan School of Public Health, United States of America (USA) 0
Division of Oncology and Pathology, LU, Sweden 0
Faculty of Medicine, Dentistry and Health Sciences (MDHS), UniMelb, Australia 0
Institute of Health and Wellbeing, University of Glasgow, United Kingdom (UK) 0
Oxford Nuffield Department of Population Health (NDPH), United Kingdom (UK) 0
ICR Division of Breast Cancer Research, United Kingdom (UK) 0
Royal North Shore Hospital (RNSH), Australia 0
Cancer Research UK Manchester Institute, UoM, United Kingdom (UK) 0
National Clinical Research Center of Cancer at Tianjin Medical University Cancer Institute and Hospital, TMU, China 0
QUT Institute of Health and Biomedical Innovation (IHBI), Australia 0
Centre for Cancer Biomarkers (CCBIO), UIB, Norway 0
Institute of Inflammation and Repair, UoM, United Kingdom (UK) 0
Key Laboratory of Cancer Prevention and Therapy at Tianjin Medical University Cancer Institute and Hospital, TMU, China 0
QUT School of Biomedical Sciences (SBMS), Australia 0
Department of Gastroenterology and Hepatology, RBWH, Australia 0
School of Medicine (SOM), UQ, Australia 0
The University of Queensland (UQ), Australia 0
Mater Research Institute - University of Queensland (MRI-UQ), Australia 0
Department of Epidemiology and Biostatistics, TMU, China 0
Sydney School of Public Health, USYD, Australia 0
Centre for Cancer Research, Westmead Institute for Medical Research, Australia 0
ANU John Curtin School of Medical Research (JCMSR), Australia 0
NSW Health Pathology, Australia 0
Central Clinical School (CCS), USYD, Australia 0
Royal Prince Alfred Hospital (RPAH), USYD, Australia 0

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER